Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|7|11|1089-1096

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.11, 2007-11, pp. : 1089-1096

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Chemokine Receptors in Allergic Diseases: Is CCR8 a Novel Therapeutic Target?

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 463-466

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of adenosine receptors in inflammatory diseases

By Shanley T.P.   Bshesh K.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 447-458

Informa Healthcare

Access to resources Recommend Favorite

CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 265-278

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4

By Pease James Edward   Horuk Richard  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 467-483

Informa Healthcare

Access to resources Recommend Favorite